Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,262 | -66,756 | -34,126 | -165,291 | -126,785 |
| Depreciation Amortization | -2,027 | -1,376 | -635 | 608 | 749 |
| Accounts receivable | 9,163 | 14,806 | 11,886 | -5,084 | -4,949 |
| Accounts payable and accrued liabilities | -1,830 | -486 | 6,272 | 1,170 | -790 |
| Other Working Capital | 12,624 | 12,075 | 10,458 | -19,989 | -25,898 |
| Other Operating Activity | 9,194 | -2,871 | -12,765 | 39,032 | 34,962 |
| Operating Cash Flow | $-74,138 | $-44,608 | $-18,910 | $-149,554 | $-122,711 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -118 | -118 |
| Purchase Of Investment | -142,591 | -96,526 | -60,332 | -226,016 | -128,918 |
| Sale Of Investment | 123,688 | 85,308 | 27,944 | 121,878 | 90,078 |
| Investing Cash Flow | $-18,903 | $-11,218 | $-32,388 | $-104,256 | $-38,958 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 860 | 860 | N/A | 193,738 | 37,895 |
| Financing Cash Flow | $860 | $860 | $N/A | $193,738 | $37,895 |
| Exchange Rate Effect | -123 | -71 | -45 | -488 | -614 |
| Beginning Cash Position | 136,885 | 136,885 | 136,885 | 197,445 | 197,445 |
| End Cash Position | 44,581 | 81,848 | 85,542 | 136,885 | 73,057 |
| Net Cash Flow | $-92,304 | $-55,037 | $-51,343 | $-60,560 | $-124,388 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,138 | -44,608 | -18,910 | -149,554 | -122,711 |
| Capital Expenditure | N/A | N/A | N/A | -118 | -118 |
| Free Cash Flow | -74,138 | -44,608 | -18,910 | -149,672 | -122,829 |